Related references
Note: Only part of the references are listed.Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
R. Schmidt et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Alzheimer disease:: Postmortem neuropathologic correlates of antemortem 1H MR Spectroscopy metabolite measurements
Kejal Kantarci et al.
RADIOLOGY (2008)
High field H-1 MRS of the hippocampus after donepezil treatment in Alzheimer disease
Robert Bartha et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease
Hideto Shinno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Longitudinal H-1 MRS changes in mild cognitive impairment and Alzheimer's disease
Kejal Kantarci et al.
NEUROBIOLOGY OF AGING (2007)
Treatment monitoring and response prediction with proton MR spectroscopy in AD
F. Jessen et al.
NEUROLOGY (2006)
Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
Elaine R. Peskind et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease - A nonrandomised controlled trial with magnetic resonance spectroscopy
Pedro J. Modrego et al.
CNS DRUGS (2006)
The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques
Pedro J. Modrego
CURRENT MEDICINAL CHEMISTRY (2006)
Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons
M Kimura et al.
NEUROSCIENCE LETTERS (2005)
Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy
PJ Modrego et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
1H MR spectroscopy using TE averaged PRESS:: A more sensitive technique to detect neuro degeneration associated with Alzheimer's disease
I Hancu et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
M Hashimoto et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation
M Sobrado et al.
NEUROSCIENCE LETTERS (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease
KRR Krishnan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
JJ Miguel-Hidalgo et al.
BRAIN RESEARCH (2002)